|
RRM1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.402600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.306000E-02 |
| Normal-vs-Stage2 |
3.328600E-01 |
| Normal-vs-Stage3 |
4.033200E-01 |
| Normal-vs-Stage4 |
3.122800E-01 |
| Stage1-vs-Stage2 |
9.751600E-01 |
| Stage1-vs-Stage3 |
2.932100E-02 |
| Stage1-vs-Stage4 |
9.650400E-01 |
| Stage2-vs-Stage3 |
1.623400E-01 |
| Stage2-vs-Stage4 |
9.862000E-01 |
| Stage3-vs-Stage4 |
2.526800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.046400E-01 |
| Normal-vs-AfricanAmerican |
4.861400E-01 |
| Normal-vs-Asian |
9.519000E-01 |
| Caucasian-vs-AfricanAmerican |
7.366000E-01 |
| Caucasian-vs-Asian |
6.594000E-01 |
| AfricanAmerican-vs-Asian |
7.492600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.731510E-02 |
| Normal-vs-Female |
7.532200E-02 |
| Male-vs-Female |
4.07880000000693E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.435600E-01 |
| Normal-vs-Extreme_Weight |
2.530400E-02 |
| Normal-vs-Obese |
8.799200E-01 |
| Normal-vs-Extreme_Obese |
3.009500E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.752800E-01 |
| Normal_Weight-vs-Obese |
4.239000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.677200E-01 |
| Extreme_Weight-vs-Obese |
4.508300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.245400E-01 |
| Obese-vs-Extreme_Obese |
9.296400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.319350E-01 |
| Normal-vs-Age(41-60Yrs) |
5.085400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.766400E-02 |
| Normal-vs-Age(81-100Yrs) |
1.621400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.078100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.054000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.154100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.334820E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.217800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.691000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.047600E-02 |
| Normal-VS-Type2 PRCC |
2.118000E-01 |
| Normal-VS-KIRP CIMP |
6.960300E-02 |
| Normal-VS-Unclassified PRCC |
9.003000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.877800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.662000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.506040E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.387500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.942800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.407590E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.161900E-02 |
| Normal-vs-N1 |
1.925050E-01 |
| Normal-vs-N2 |
7.539800E-01 |
| N0-vs-N1 |
1.024150E-02 |
| N0-vs-N2 |
3.853600E-01 |
| N1-vs-N2 |
6.917600E-01 |
|
|
